Liver X receptors: new drug targets to treat Type 2 diabetes?

Author： Steffensen Knut R   Gustafsson Jan-Åke  

Publisher： Future Medicine

ISSN： 1746-0875

Source： Future Lipidology, Vol.1, Iss.2, 2006-04, pp. : 181-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vildagliptin: novel pharmacological approach to treat Type 2 diabetes

By Ahréén Bo  

Therapy, Vol. 5, Iss. 1, 2008-01 ,pp. : 79-90

Future Medicine

Access to resources Recommend Favorite

New treatments for type 2 diabetes

By Cascales Laura  

Medical Writing, Vol. 21, Iss. 4, 2012-12 ,pp. : 279-283

Maney Publishing

Access to resources Recommend Favorite

Liver X receptors and copper metabolism: New frontiers for the oxysterol receptors

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1371-1371

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimer's Disease

By  

Recent Patents on CNS Drug Discovery, Vol. 5, Iss. 2, 2010-01 ,pp. : 109-117

Bentham Science Publishers

Access to resources Recommend Favorite

Pediatric drug development programs for type 2 diabetes: A review

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 731-738

John Wiley & Sons Inc

Access to resources Recommend Favorite